During the past decade, Peking University Shougang Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 3 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 3 clinical trials were completed. i.e. 13.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peking University Shougang Hospital" #1 sponsor was "Peking University People's Hospital" with 10 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials sponsored, "Peking University First Hospital" with 2 trials sponsored, "Akeso" with 1 trials sponsored and "Beijing Institute of Heart, Lung and Blood Vessel Diseases" with 1 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peking University Shougang Hospital" #1 collaborator was "Peking University Shougang Hospital" with 11 trials as a collaborator, "Aerospace 731 Hospital" with 2 trials as a collaborator, "Beijing Jingmei Group General Hospital" with 2 trials as a collaborator, "Beijing Jishuitan Hospital" with 2 trials as a collaborator and "Beijing Luhe Hospital" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Peking University Shougang Hospital" are "Advanced Cancer" (2 trials), "Toxicity" (2 trials), "Abnormal Mucus Secretions" (1 trials), "Acne Vulgaris" (1 trials) and "Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma" (1 trials). Many other conditions were trialed in "Peking University Shougang Hospital" in a lesser frequency.

Most popular intervention types in "Peking University Shougang Hospital" are "Drug" (22 trials), "Other" (7 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apatinib" (2 trials), "placebo" (2 trials), "611 150mg" (1 trials) and "611 300mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peking University Shougang Hospital" are 31 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 13 active trials in "Peking University Shougang Hospital". 2 are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Peking University Shougang Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Peking University Shougang Hospital, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".